Analystreport

Aduro BioTech Inc (NASDAQ: ADRO) had its "buy" rating re-affirmed by analysts at Canaccord Genuity.

ADURO BIOTECH  (ADRO) 
Last aduro biotech earnings: 3/9 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.aduro.com